Changing practice patterns for breast cancer radiation therapy with clinical pathways: An analysis of hypofractionation in a large, integrated cancer center network Malolan S. Rajagopalan, MD, John C. Flickinger, MD, Dwight E. Heron, MD, Sushil Beriwal, MD Practical Radiation Oncology Volume 5, Issue 2, Pages 63-69 (March 2015) DOI: 10.1016/j.prro.2014.10.004 Copyright © 2015 American Society for Radiation Oncology Terms and Conditions
Figure 1 Rate of breast hypofractionation utilization in women 70+ years of age in the network. The rate of breast hypofractionation utilization is graphed over time and the data between 2005 and 2013 is depicted for both academic (orange) and community (blue) radiation oncologists. A substantial increase in adoption of hypofractionated whole breast irradiation (HF-WBI) follows the pathway modification in January 2011. Practical Radiation Oncology 2015 5, 63-69DOI: (10.1016/j.prro.2014.10.004) Copyright © 2015 American Society for Radiation Oncology Terms and Conditions
Figure 2 Key features of effective clinical pathways. The key design elements of a successful clinical pathway include internal development, implementation with each patient encounter, an easily accessible mechanism of distribution, and a measure of accountability. Practical Radiation Oncology 2015 5, 63-69DOI: (10.1016/j.prro.2014.10.004) Copyright © 2015 American Society for Radiation Oncology Terms and Conditions